Get conference updates straight to your inbox.
Expert Interviews
The COMMANDS trial evaluated frontline luspatercept in transfusion-dependent patients with lower-risk MDS and anemia.
An expert on site at ASH 2024 discusses the MRD negativity data from CARTITUDE-4.
Meeting News
2025 Conference Coverage
The AACR Annual Meeting 2025 took place April 25-30 in Chicago, featuring the latest advances in cancer science and ...
Coverage of the 2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR.
Coverage of the 2025 ASCO Annual Meeting from Blood Cancers Today, a Formedics property.
EHA 2025 unites global hematology experts to learn, connect & advance care—June 12–16 in Milan, Italy.
Insights on CLL
ASH 2024 Coverage
Highlights from the 66th ASH Annual Meeting and Exposition focused on CAR-T cell therapy
Key research and clinical insights on lymphoma care presented at the 66th ASH Annual Meeting and Exposition
The latest research and clinical guidance in myelodysplastic syndromes presented at the 2024 ASH Annual Meeting
Highlights from the 66th ASH Annual Meeting and Exposition focused on the most recent updates in myelofibrosis care
Review key highlights presented at the 66th ASH Annual Meeting, including the latest developments in hematologic malignancies
2024 Conference Coverage
The Twelfth Annual Meeting of the Society of Hematologic Oncology was held September 4-7, 2024, in Houston, Texas.
The Pan Pacific Lymphoma Conference took place July 15-19, 2024 in Lahaina, HI.
The European Hematology Association (EHA) 2024 Congress was held June 13-16, 2024 in Madrid, Spain.
The 2024 American Society of Clinical Oncology Annual Meeting was held May 31-June 4 in Chicago, Illinois.
The American Association for Cancer Research (AACR) Annual Meeting 2024 took place April 5-10 in San Diego, California.
The 2024 ASPHO Conference featured education and networking events for advanced practice providers.
The 2024 Tandem Meetings featured the latest in hematopoietic stem cell transplantation and cellular therapy.
Review key highlights presented at the 66th ASH Annual Meeting, including the latest developments in hematologic malignancies
2023 Conference Coverage
Blood Cancers Today covers updates in hematologic malignancies at JADPRO Live 2023, including myeloma news.
The latest in clinical trials, analysis of the impact of driver mutations in MPNs, and more.
The 38th SITC Annual Meeting covered topics on blood cancers and immunotherapies.
The 20th International Myeloma Society Annual Meeting and Exposition was held September 27-30 in Athens, Greece.
The 2023 SNMMI Annual Meeting took place from June 24 to June 27 in Chicago.
The European Hematology Association (EHA) 2023 Congress was held June 8-11, 2023, in Frankfurt, Germany.
The American Association for Cancer Research (AACR) Annual Meeting 2023 took place April 14-19 in Orlando, Florida.
The EHA-EBMT Fifth European CAR T-Cell Meeting was held February 9-11 in Rotterdam, Netherlands.
The AACR Special Conference: Acute Myeloid Leukemia and Myelodysplastic Syndrome took place from January 23-25, 2023.
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
Knowledge Hubs
Meeting News
2025 Conference Coverage
The AACR Annual Meeting 2025 took place April 25-30 in Chicago, featuring the latest advances in cancer science and ...
Coverage of the 2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR.
Coverage of the 2025 ASCO Annual Meeting from Blood Cancers Today, a Formedics property.
EHA 2025 unites global hematology experts to learn, connect & advance care—June 12–16 in Milan, Italy.
Insights on CLL
;
ASH 2024 Coverage
Highlights from the 66th ASH Annual Meeting and Exposition focused on CAR-T cell therapy
Key research and clinical insights on lymphoma care presented at the 66th ASH Annual Meeting and Exposition
The latest research and clinical guidance in myelodysplastic syndromes presented at the 2024 ASH Annual Meeting
Highlights from the 66th ASH Annual Meeting and Exposition focused on the most recent updates in myelofibrosis care
Review key highlights presented at the 66th ASH Annual Meeting, including the latest developments in hematologic malignancies
;
2024 Conference Coverage
The Twelfth Annual Meeting of the Society of Hematologic Oncology was held September 4-7, 2024, in Houston, Texas.
The Pan Pacific Lymphoma Conference took place July 15-19, 2024 in Lahaina, HI.
The European Hematology Association (EHA) 2024 Congress was held June 13-16, 2024 in Madrid, Spain.
The 2024 American Society of Clinical Oncology Annual Meeting was held May 31-June 4 in Chicago, Illinois.
The American Association for Cancer Research (AACR) Annual Meeting 2024 took place April 5-10 in San Diego, California.
The 2024 ASPHO Conference featured education and networking events for advanced practice providers.
The 2024 Tandem Meetings featured the latest in hematopoietic stem cell transplantation and cellular therapy.
Review key highlights presented at the 66th ASH Annual Meeting, including the latest developments in hematologic malignancies
2023 Conference Coverage
Blood Cancers Today covers updates in hematologic malignancies at JADPRO Live 2023, including myeloma news.
The latest in clinical trials, analysis of the impact of driver mutations in MPNs, and more.
The 38th SITC Annual Meeting covered topics on blood cancers and immunotherapies.
The 20th International Myeloma Society Annual Meeting and Exposition was held September 27-30 in Athens, Greece.
The 2023 SNMMI Annual Meeting took place from June 24 to June 27 in Chicago.
The European Hematology Association (EHA) 2023 Congress was held June 8-11, 2023, in Frankfurt, Germany.
The American Association for Cancer Research (AACR) Annual Meeting 2023 took place April 14-19 in Orlando, Florida.
The EHA-EBMT Fifth European CAR T-Cell Meeting was held February 9-11 in Rotterdam, Netherlands.
The AACR Special Conference: Acute Myeloid Leukemia and Myelodysplastic Syndrome took place from January 23-25, 2023.
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
Knowledge Hubs
Get conference updates straight to your inbox.
Expert Interviews
The COMMANDS trial evaluated frontline luspatercept in transfusion-dependent patients with lower-risk MDS and anemia.
An expert on site at ASH 2024 discusses the MRD negativity data from CARTITUDE-4.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.